Sequoia China, HighLight Capital Back $16M Series A Round In US Biotech Start-Up

Sequoia Capital China and Chinese healthcare-focused investment firm HighLight Capital have backed a US$16 million series A round of financing in America-based biotechnology company Cullgen Inc., according to a statement released on Wednesday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

LEAVE A REPLY